Clinical and biomarker changes in dominantly inherited Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

http://www.wikidata.org/entity/Q29619940

about

Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study.In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques.Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.Revolutionizing Alzheimer's disease and clinical trials through biomarkers Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction The amyloid hypothesis of Alzheimer's disease at 25 years Can physical exercise in old age improve memory and hippocampal function?Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches Three Large-Scale Functional Brain Networks from Resting-State Functional MRI in Subjects with Different Levels of Cognitive Impairment Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD Role of HIV in amyloid metabolism Recent advances in the application of metabolomics to Alzheimer's Disease Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease Advances in Alzheimer's disease drug development The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria Reevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis Genetic heterogeneity in Alzheimer disease and implications for treatment strategies Self-propagation of pathogenic protein aggregates in neurodegenerative diseases Therapeutic and diagnostic challenges for frontotemporal dementia Alternative neural circuitry that might be impaired in the development of Alzheimer disease Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers Harmonized diagnostic criteria for Alzheimer's disease: recommendations Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer's disease?Neurodegenerative diseases: expanding the prion concept Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease Ushering in the study and treatment of preclinical Alzheimer disease Network-based biomarkers in Alzheimer's disease: review and future directions Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Genetic markers in biological fluids for aging-related major neurocognitive disorder Hypertension: a harbinger of stroke and dementia Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

P2860

Q22001054-46D03C15-E977-434C-AB90-31252AA0E2DB Q22001055-3E7C80E5-FA29-4AF8-AD9E-7ADD57FFE1F5 Q22252525-648F1956-169E-4651-B9FF-F809D4FD7049 Q24040265-C44B3EEC-B546-4CC5-9591-FBC7744D871C Q26744882-45122B90-9AEC-464B-85B3-C3BD6A882FDC Q26745936-2FF13949-EEA8-4444-8332-E1C67020ACDB Q26749528-D18C6DCB-744F-4B97-9848-B9D5426EDAE7 Q26766517-BB2D6E0E-A104-41B1-9AEA-B822487708E9 Q26770708-D9E747BC-BEE0-4605-BCAB-ED5544B716B0 Q26772021-DA6181D6-B2DB-4418-9674-D1670FB5B021 Q26774418-C3453CDB-EE0E-499D-B0E0-0E1E5443C5E3 Q26774743-2701403F-AED4-4ACC-9D57-0CFCC51459CE Q26781815-2E310DFD-D452-447B-BB8C-CB24CF959B99 Q26784569-9AB5D094-E6D0-4B8E-AFD5-BF33630C7969 Q26801666-02F2B715-0566-4750-A9E4-C5CC6C355DB2 Q26824179-B463FA9B-9B3C-4AEA-B8AB-C9FF1F0E42B0 Q26828606-D4788FC5-372E-42F2-AA1F-779837BEB52B Q26829899-94F6043D-545B-43A0-A100-1FD0033A6F86 Q26849352-261B562C-0512-4BD2-B179-BF63E7708BC3 Q26849380-8B758332-D2AF-4121-8EA5-85E0D7F01481 Q26853347-C4A25F5A-EB01-4DD4-9326-9ECCCB0525BC Q26864063-60B9BA25-8BDB-4812-84AE-513C82EC1E89 Q26864926-3DBF5AD2-8640-4529-9A20-D7ECCE35E1FD Q26995432-F48A7ADB-BAA9-40FA-8D03-F7D6B4450064 Q26995802-732C8901-94B0-4082-8524-5ABE11682F20 Q26996441-6924E08A-7D26-4A45-86DA-248F40F5E9A5 Q26998919-0BE36064-8E63-4396-9C49-A10F503A8313 Q27001223-4A8FE6D6-4E24-4FE1-B552-F189AD3E5BEE Q27008249-F45E40C1-0025-4997-AFD0-42ADA12EC59F Q27009157-4752036A-6718-4219-AF8E-9E6E6EAD51ED Q27011370-470FBB15-E9DE-4D93-9E7B-A04B93BD7849 Q27011744-9F3EA3DD-B90A-4FC4-B113-6E5409AEB5BF Q27012950-DC7F83F5-BA92-4380-986A-1FF7A4EE13C6 Q27014791-47017189-B622-4AD2-BA13-3F29ACFE6082 Q27023864-2ABA1506-340B-440C-B92E-44D31B2FE8B2 Q27027319-5ACA0248-3AB1-44F3-B4E5-288E88E01CF4 Q27027348-21928BF3-7A22-4E4C-A1A5-28C4F62AEA3E Q27027494-A5CB63C8-799D-4858-906C-5B93110968A8 Q27301246-92942114-7ED9-4823-B200-624A6581A0B8 Q27303745-6FB8E6AD-3652-496B-A576-473ABE2582CC

P2860

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

http://www.wikidata.org/entity/Q29619940

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@ast

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@en

type

label

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@ast

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@en

prefLabel

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@ast

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@en

P1433

Q29619940-DF015BCD-CB6D-4530-95E8-F68B473B4417

P1476

Q29619940-05315D61-FDA0-432D-86DE-99F443AD5DE0

P2093

Q29619940-02B3DC0F-ABEE-413A-8549-79199B79E7FD

Q29619940-059EDED0-E704-474B-A52E-B1FFAE433D0E

Q29619940-1E8ACCEF-8FDF-4389-9BEE-B5C28FDAFB47

Q29619940-2E0A4A43-EC59-4397-9AED-E2D6CE314D16

Q29619940-2FEBE7A5-F827-42A3-BD1D-568ABE76E0F2

Q29619940-337B95A2-8305-428F-AB86-67ECF5B9081E

Q29619940-4D1A20BC-2F2A-47E0-9E07-6EC183BDF5E2

Q29619940-67BB49C5-A1A6-4A15-96B2-CAF1CF83B23F

Q29619940-7293F94F-B141-4C9E-AD37-06C635D5CCF6

Q29619940-8E701657-48C7-4378-AA0A-89A49DCFA782

P2860

Q29619940-01E08C1E-F09A-48C5-BBD1-8E55A52E23A9

Q29619940-042D6A0B-D090-409E-9196-B6ED933C7676

Q29619940-0CC94BDE-9EE3-4220-83AB-6F5465B87DDB

Q29619940-1D465FCE-8133-456F-B76E-EAC9951EE4B7

Q29619940-285EDAA2-B263-4C16-9AE4-2B1CD90FD52D

Q29619940-2A2A83B5-FFC5-4669-B371-8B28C4F84525

Q29619940-2FE83D63-CA69-47D0-A8BF-2A88DF7F8749

Q29619940-381D6559-543A-40A9-B3CC-F8BAD39B43C9

Q29619940-477110DD-EB4D-4052-B8C6-72B1CCD7F8AE

Q29619940-5DD309BD-0561-4249-BBFA-397E474D8E63

P304

Q29619940-D4A75434-D13E-467A-B5B7-9BBD2382EDC2

P31

Q29619940-9CD40575-D802-41B5-A945-9E35EECB12ED

P3181

Q29619940-246E8227-36BA-4EF1-AF24-DF8493FB4801

P356

Q29619940-4527FDA5-01DB-4E3F-B9E1-A4094D492308

P407

Q29619940-CD637E2D-BA43-41AF-9299-DE700B66FCA7

P433

Q29619940-FB41F9F9-1DF4-4971-80B6-85B46E27BEF2

P478

Q29619940-7C90D3A3-BF04-4D22-A187-613AF8DC75B6

P50

Q29619940-10B6E019-5FC2-40EB-BD97-53ABEBD40CA8

Q29619940-21B94A87-AB89-4965-97D7-2706A0381591

Q29619940-3123E04C-B332-44CF-A61C-498112ECB19A

Q29619940-35530C51-70A8-48AC-8BF6-726271001761

Q29619940-446E0C79-737E-443D-9766-9C3E6B5672F9

Q29619940-566008D7-F9A0-44F8-A5C2-5BDF879C51D6

Q29619940-6C2935C2-7423-4764-A41E-C94306299E9B

Q29619940-770B50C5-99FC-456E-964A-5E0A4265589D

Q29619940-8FCC69F4-8A56-45C3-9D17-904E49959D6B

Q29619940-AA13A6F3-1DD8-4655-A416-4EE5941EB16E

P577

Q29619940-AB8F3959-50B2-4A58-BCEA-7B7C97FF3922

P698

Q29619940-49080A23-C457-4D0F-A438-4D7D71B9EF48

P921

Q29619940-2E81F4EA-4A95-4232-A2F6-7B216D62B64D

Q29619940-91932709-EC45-4DBD-95C9-C6CA99E42935

P932

Q29619940-C526D3C9-9467-4802-B3DD-ED621DA43D6C

P3181

P356

P1433

The New England Journal of Medicine

P1476

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

@en

P2093

Angela Oliver

http://www.w3.org/2001/XMLSchema#string

Anna Santacruz

http://www.w3.org/2001/XMLSchema#string

Bernardino Ghetti

http://www.w3.org/2001/XMLSchema#string

Chengjie Xiong

http://www.w3.org/2001/XMLSchema#string

Daniel S Marcus

http://www.w3.org/2001/XMLSchema#string

Eric McDade

http://www.w3.org/2001/XMLSchema#string

John M Ringman

http://www.w3.org/2001/XMLSchema#string

Krista Moulder

http://www.w3.org/2001/XMLSchema#string

Nigel J Cairns

http://www.w3.org/2001/XMLSchema#string

Reisa A Sperling

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

“Mini-mental state”

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

The Alzheimer's disease neuroimaging initiative.

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.

P304

795-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

232192

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1202753

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

William E. Klunk

Peter R Schofield

Randall J. Bateman

David M. Holtzman

P577

2012-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22784036

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3474597

http://www.w3.org/2001/XMLSchema#string